Physician

Hematology

Dr. William R. Friedenberg is an expert in the field of Hematology. He went to Jefferson Medical College. Dr. William R. Friedenberg has written publications. He has 44 publications published with PubMed. The lastest paper is: 'Infusional chemotherapy for non-Hodgkin's lymphoma.'

Publications

---

• The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and al...
• Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or r...
• Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment ...
• Clinical cancer. 5. Progress in acute leukemia.
• Intravenous diazepam administration.
• Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
• Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenström's macroglobulinemia.
• Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) wi...
• Immune thrombocytopenia after losartan therapy.
• Skeletal muscle lymphoma.
• A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
• Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group.
• The treatment of multiple myeloma with docetaxel (an ECOG study).
• Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Gr...
• The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapy.
• The effect of lithium carbonate on lymphocyte, granulocyte, and platelet function.
• Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease.
• Serum ferritin as a means of assessing body iron stores.
• Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981.
• Local intra-arterial streptokinase therapy for acute peripheral arterial occlusions. Should thrombolytic therapy replace embolectomy?
• Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979).
• Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.
• New technologies in diagnosis and classification of malignancy.
• Granulocyte dysfunction and myotonic dystrophy.
• High-dose cytosine arabinoside-associated pancreatitis.
• High-dose dexamethasone for refractory or relapsing multiple myeloma.
• Treatment of advanced non-Hodgkin's lymphoma in adults.
• Polypharmacy in fatal clozapine-associated agranulocytosis.
• High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.
• Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
• Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders.
• Atypical purpura fulminans with benign monoclonal gammopathy.
• Severe preeclampsia presenting as hepatobiliary disease.
• Hyperimmunoglobulin E syndrome: response to transfer factor and ascorbic acid therapy.
• Platelet dysfunction associated with cardiopulmonary bypass.
• Local versus regional procurement and distribution of granulocytes.
• Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndr...
• Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.
• Multi-drug resistance in chronic lymphocytic leukemia.
• Infusional chemotherapy for non-Hodgkin's lymphoma.
• Intensifying induction therapy in acute myeloid leukemia by an infusional chemotherapy schedule.
• Superwarfarin poisoning.
• The bactericidal defect of neutrophil function with lithium therapy.

Schools

---

• Thomas Jefferson University

• Michael Reese Hospital and Med Center

• Los Angeles Co Harbor

• University of Washington

• Western Mass Med Center

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• Harbor - UCLA Medical Center
• Jefferson Medical College

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Bradley W. Lash, MD This Doctor is OpenDoctor Recommended.
	Dr. Philip A. Lowry, MD This Doctor is OpenDoctor Recommended.
	Dr. Aref Agheli, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward T. O'Brien, MD
	Dr. Patrick R. Bergevin, MD This Doctor is OpenDoctor Recommended.
	Dr. Bruce D. Boselli, MD This Doctor is OpenDoctor Recommended.
	Dr. Cynthia A. Lynch, MD This Doctor is OpenDoctor Recommended.
	Dr. Ricardo N. Sarli, MD This Doctor is OpenDoctor Recommended.
	Dr. Panit H. Srivatana, MD This Doctor is OpenDoctor Recommended.
	Dr. Mahendra K. Shah, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog